drugset
drugset / Trial / NCT05155072

Clinical Trial to Evaluate the Safety and Pharmacokinetic/Pharmacodynamic Characteristics of DW1903

NCT05155072 ↗

Phase 1 Completed 31 enrolled Daewon Pharmaceutical Co., Ltd.
RandomizedCrossoverOpen-labelTreatment

Summary

A Randomized, Open-label, Oral in healthy male volunteers

Timeline

Start
2020-05-15
Primary completion
2020-09-07
Completion
2020-09-07

Drugs

EvaluationDrugModalityDoseRoute
Subject DW1903 Unknown — Oral
Subject DW1903-R1 Unknown — Oral
Subject DW1903-R2 Unknown — Oral

Indications

gastritis